Your browser doesn't support javascript.
loading
Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines.
Dhuri, Karishma; Pradeep, Sai Pallavi; Shi, Jason; Anastasiadou, Eleni; Slack, Frank J; Gupta, Anisha; Zhong, Xiao-Bo; Bahal, Raman.
Affiliation
  • Dhuri K; Department of Pharmaceutical Science, University of Connecticut, Storrs, CT, 06269, USA.
  • Pradeep SP; Department of Pharmaceutical Science, University of Connecticut, Storrs, CT, 06269, USA.
  • Shi J; Department of Pharmaceutical Science, University of Connecticut, Storrs, CT, 06269, USA.
  • Anastasiadou E; HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
  • Slack FJ; HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
  • Gupta A; School of Pharmacy, University of Saint Joseph, West Hartford, CT, 06117, USA.
  • Zhong XB; Department of Pharmaceutical Science, University of Connecticut, Storrs, CT, 06269, USA.
  • Bahal R; Department of Pharmaceutical Science, University of Connecticut, Storrs, CT, 06269, USA. raman.bahal@uconn.edu.
Pharm Res ; 39(11): 2709-2720, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36071352
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Nucleic Acids / MicroRNAs / Lymphoma Limits: Humans Language: En Journal: Pharm Res Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Nucleic Acids / MicroRNAs / Lymphoma Limits: Humans Language: En Journal: Pharm Res Year: 2022 Type: Article Affiliation country: United States